search button

Mutations of the TERT promoter are associated with aggressiveness and recurrence/distant metastasis of papillary thyroid carcinoma

  • Authors:
    • Riming Liu
    • Yulan Li
    • Weixin Chen
    • Jianglin Cong
    • Zhengfang Zhang
    • Li Ma
    • Lina Chu
    • Hui Xiao
    • Yanhong Zhang
    • Yongming Liu
    • Yimin Xu
    • Qin Yu
    • Xin Yang
    • Chengming Sun

  • View Affiliations

  • Published online on: July 27, 2020     https://doi.org/10.3892/ol.2020.11904
  • Article Number: 50
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Several previous studies have shown that mutations in B‑Raf proto‑oncogene (BRAF) and telomerase reverse transcriptase (TERT) can be used for the diagnosis and prognosis of papillary thyroid carcinoma (PTC). However, whether mutations in BRAF and the TERT promoter may improve the accurate identification and risk stratification of high‑risk patients in the early stage of PTC remains unclear and requires further investigation. In the present study, mutations in BRAF and the TERT promoter were examined in 205 patients using PCR and Sanger DNA sequencing. The potential association between mutations in these two genes and the clinicopathological characteristics of patients with PTC was then analyzed. BRAF mutations were identified in 169/205 (82.4%) patients, whereas only 8/205 (3.9%) patients presented mutations in the TERT promoter, seven patients exhibited a C228T mutation, and the remaining one had a C250T mutation. There were 6/205 (2.9%) patients with mutations in both BRAF and the TERT promoter. Importantly, compared with patients with no mutations, patients with mutations in BRAF were more likely to exhibit mutations in the TERT promoter. A significant difference in lymph node metastasis was found between the BRAF V600E mutation group and the group without mutations in BRAF. Mutations in the TERT promoter were significantly correlated with older age, extrathyroidal invasion, tumor multifocality and advanced tumor/node/metastasis stage, which are associated with the aggressiveness of PTC. Moreover, compared with patients exhibiting mutations in BRAF, mutations in the TERT promoter were found to be significantly associated with aggressive clinicopathological features and higher risk of recurrence or distant metastasis. Collectively, mutations in the TERT promoter were not frequent, but were significantly correlated with more aggressive clinicopathological features of PTC. Therefore, mutations in the TERT promoter may be an important factor in the genetic background of PTC, and detection of such mutations may help the accurate identification and management of high‑risk patients with recurrent or distant metastasis.
View Figures
View References

Related Articles

Journal Cover

October-2020
Volume 20 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.9
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 6.3
  • CiteScore Rank: Q2: #119/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.725
  • SCImago Journal Rank (SJR): 0.639
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Liu R, Li Y, Chen W, Cong J, Zhang Z, Ma L, Chu L, Xiao H, Zhang Y, Liu Y, Liu Y, et al: Mutations of the <em>TERT</em> promoter are associated with aggressiveness and recurrence/distant metastasis of papillary thyroid carcinoma. Oncol Lett 20: 50, 2020
APA
Liu, R., Li, Y., Chen, W., Cong, J., Zhang, Z., Ma, L. ... Sun, C. (2020). Mutations of the <em>TERT</em> promoter are associated with aggressiveness and recurrence/distant metastasis of papillary thyroid carcinoma. Oncology Letters, 20, 50. https://doi.org/10.3892/ol.2020.11904
MLA
Liu, R., Li, Y., Chen, W., Cong, J., Zhang, Z., Ma, L., Chu, L., Xiao, H., Zhang, Y., Liu, Y., Xu, Y., Yu, Q., Yang, X., Sun, C."Mutations of the <em>TERT</em> promoter are associated with aggressiveness and recurrence/distant metastasis of papillary thyroid carcinoma". Oncology Letters 20.4 (2020): 50.
Chicago
Liu, R., Li, Y., Chen, W., Cong, J., Zhang, Z., Ma, L., Chu, L., Xiao, H., Zhang, Y., Liu, Y., Xu, Y., Yu, Q., Yang, X., Sun, C."Mutations of the <em>TERT</em> promoter are associated with aggressiveness and recurrence/distant metastasis of papillary thyroid carcinoma". Oncology Letters 20, no. 4 (2020): 50. https://doi.org/10.3892/ol.2020.11904